Table 2 Selection of source and study populations
Inclusion/exclusion criteria | n (%) |
|---|---|
Source Population | |
GHP members aged ≥18 years who received myelosuppressive chemotherapy from 01/01/04 - 4/30/10 | 3823 (100.0) |
plus continuous health benefits during 60-day pretreatment period | 3660 (95.7) |
plus ≥2 claims with primary cancer diagnosis beginning 60 days prior to chemotherapy initiation | 3193 (83.5) |
Study Population | |
plus admission to acute care, short stay hospital during chemotherapy course | 772 (20.2) |
plus admitted to hospital within GHS | 373 (9.8) |
plus ANC data available within 1 day of hospital admission | 357 (9.3) |